Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR–dependent motility in alveolar rhabdomyosarcoma cells

Overview of attention for article published in BMC Cancer, April 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 39 Dimensions

Readers on

mendeley: 85 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

ANTIBODY-PROTAMINE FUSIONS AS TARGETING COMPOUNDS OF A PROTAMINE-BASED NANOPARTICLE

Application WO-2022243518-A1

World Intellectual Property Organisation (WIPO)

ELECTROSTATIC NANOPARTICLES AND USE THEREOF

Application WO-2022117731-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.